Skip to main content
Top
Published in: Cancer Causes & Control 9/2013

01-09-2013 | Original paper

Pregnancy-related characteristics and breast cancer risk

Authors: Theodore M. Brasky, Yanli Li, David J. Jaworowicz Jr., Nancy Potischman, Christine B. Ambrosone, Alan D. Hutson, Jing Nie, Peter G. Shields, Maurizio Trevisan, Carole B. Rudra, Stephen B. Edge, Jo L. Freudenheim

Published in: Cancer Causes & Control | Issue 9/2013

Login to get access

Abstract

Breast tissues undergo extensive physiologic changes during pregnancy, which may affect breast carcinogenesis. Gestational hypertension, preeclampsia/eclampsia, gestational diabetes, pregnancy weight gain, and nausea and vomiting (N&V) during pregnancy may be indicative of altered hormonal and metabolic profiles and could impact breast cancer risk. Here, we examined associations between these characteristics of a woman’s pregnancy and her subsequent breast cancer risk. Participants were parous women that were recruited to a population-based case–control study (Western New York Exposures and Breast Cancer Study). Cases (n = 960), aged 35–79 years, had incident, primary, histologically confirmed breast cancer. Controls (n = 1,852) were randomly selected from motor vehicle records (<65 years) or Medicare rolls (≥65 years). Women were queried on their lifetime pregnancy experiences. Multivariable-adjusted logistic regression was used to estimate odds ratios (ORs) and 95 % confidence intervals (CIs). N&V during pregnancy was inversely associated with breast cancer risk. Relative to those who never experienced N&V, ever experiencing N&V was associated with decreased risk (OR 0.69, 95 % CI 0.56–0.84) as were increased N&V severity (p trend < 0.001), longer duration (p trend < 0.01), and larger proportion of affected pregnancies (p trend < 0.0001) among women with ≥3 pregnancies. Associations were stronger for more recent pregnancies (<5 years). Findings did not differ by menopausal status or breast cancer subtype including estrogen receptor and HER2 expression status. Other pregnancy characteristics examined were not associated with risk. We observed strong inverse associations between pregnancy N&V and breast cancer risk. Replication of these findings and exploration of underlying mechanisms could provide important insight into breast cancer etiology and prevention.
Literature
1.
go back to reference Key T, Appleby P, Barnes I, Reeves G (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94:606–616PubMedCrossRef Key T, Appleby P, Barnes I, Reeves G (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94:606–616PubMedCrossRef
2.
go back to reference Key TJ, Verkasalo PK (1999) Endogenous hormones and the aetiology of breast cancer. Breast Cancer Res 1:18–21PubMedCrossRef Key TJ, Verkasalo PK (1999) Endogenous hormones and the aetiology of breast cancer. Breast Cancer Res 1:18–21PubMedCrossRef
3.
go back to reference Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE (2004) Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 96:1856–1865PubMedCrossRef Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE (2004) Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 96:1856–1865PubMedCrossRef
4.
go back to reference Muti P (2004) The role of endogenous hormones in the etiology and prevention of breast cancer: the epidemiological evidence. Ann N Y Acad Sci 1028:273–282PubMedCrossRef Muti P (2004) The role of endogenous hormones in the etiology and prevention of breast cancer: the epidemiological evidence. Ann N Y Acad Sci 1028:273–282PubMedCrossRef
5.
go back to reference Toniolo PG (1997) Endogenous estrogens and breast cancer risk: the case for prospective cohort studies. Environ Health Perspect 105(Suppl 3):587–592PubMedCrossRef Toniolo PG (1997) Endogenous estrogens and breast cancer risk: the case for prospective cohort studies. Environ Health Perspect 105(Suppl 3):587–592PubMedCrossRef
6.
7.
go back to reference Bernstein L (2002) Epidemiology of endocrine-related risk factors for breast cancer. J Mammary Gland Biol Neoplasia 7:3–15PubMedCrossRef Bernstein L (2002) Epidemiology of endocrine-related risk factors for breast cancer. J Mammary Gland Biol Neoplasia 7:3–15PubMedCrossRef
8.
go back to reference Kelsey JL, Gammon MD, John EM (1993) Reproductive factors and breast cancer. Epidemiol Rev 15:36–47PubMed Kelsey JL, Gammon MD, John EM (1993) Reproductive factors and breast cancer. Epidemiol Rev 15:36–47PubMed
9.
go back to reference Helewa M, Levesque P, Provencher D, Lea RH, Rosolowich V, Shapiro HM (2002) Breast cancer, pregnancy, and breastfeeding. J Obstet Gynaecol Can 24:164–180 quiz 81-4PubMed Helewa M, Levesque P, Provencher D, Lea RH, Rosolowich V, Shapiro HM (2002) Breast cancer, pregnancy, and breastfeeding. J Obstet Gynaecol Can 24:164–180 quiz 81-4PubMed
10.
go back to reference Genin AS, Lesieur B, Gligorov J, Antoine M, Selleret L, Rouzier R (2012) Pregnancy-associated breast cancers: do they differ from other breast cancers in young women? Breast 21:550–555PubMedCrossRef Genin AS, Lesieur B, Gligorov J, Antoine M, Selleret L, Rouzier R (2012) Pregnancy-associated breast cancers: do they differ from other breast cancers in young women? Breast 21:550–555PubMedCrossRef
11.
go back to reference Fornetti J, Martinson H, Borges V, Schedin P (2012) Emerging targets for the prevention of pregnancy-associated breast cancer. Cell Cycle 11:639–640PubMedCrossRef Fornetti J, Martinson H, Borges V, Schedin P (2012) Emerging targets for the prevention of pregnancy-associated breast cancer. Cell Cycle 11:639–640PubMedCrossRef
12.
go back to reference Lyons TR, O’Brien J, Borges VF et al (2011) Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. Nat Med 17:1109–1115PubMedCrossRef Lyons TR, O’Brien J, Borges VF et al (2011) Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. Nat Med 17:1109–1115PubMedCrossRef
13.
go back to reference Hansen RK, Bissell MJ (2000) Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones. Endocr Relat Cancer 7:95–113PubMedCrossRef Hansen RK, Bissell MJ (2000) Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones. Endocr Relat Cancer 7:95–113PubMedCrossRef
14.
go back to reference Weissgerber TL, Wolfe LA (2006) Physiological adaptation in early human pregnancy: adaptation to balance maternal-fetal demands. Appl Physiol Nutr Metab 31:1–11PubMedCrossRef Weissgerber TL, Wolfe LA (2006) Physiological adaptation in early human pregnancy: adaptation to balance maternal-fetal demands. Appl Physiol Nutr Metab 31:1–11PubMedCrossRef
15.
go back to reference Nechuta S, Paneth N, Velie EM (2010) Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature. Cancer Causes Control 21:967–989PubMedCrossRef Nechuta S, Paneth N, Velie EM (2010) Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature. Cancer Causes Control 21:967–989PubMedCrossRef
16.
go back to reference Millikan RC, Newman B, Tse CK et al (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109:123–139PubMedCrossRef Millikan RC, Newman B, Tse CK et al (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109:123–139PubMedCrossRef
17.
go back to reference Troisi R, Weiss HA, Hoover RN et al (1998) Pregnancy characteristics and maternal risk of breast cancer. Epidemiology 9:641–647PubMedCrossRef Troisi R, Weiss HA, Hoover RN et al (1998) Pregnancy characteristics and maternal risk of breast cancer. Epidemiology 9:641–647PubMedCrossRef
18.
go back to reference Bonner MR, Han D, Nie J et al (2005) Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure. Cancer Epidemiol Biomarkers Prev 14:53–60PubMed Bonner MR, Han D, Nie J et al (2005) Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure. Cancer Epidemiol Biomarkers Prev 14:53–60PubMed
19.
go back to reference Han D, Rogerson PA, Nie J et al (2004) Geographic clustering of residence in early life and subsequent risk of breast cancer (United States). Cancer Causes Control 15:921–929PubMedCrossRef Han D, Rogerson PA, Nie J et al (2004) Geographic clustering of residence in early life and subsequent risk of breast cancer (United States). Cancer Causes Control 15:921–929PubMedCrossRef
20.
go back to reference Allred DC, Harvey JM, Berardo M, Clark GM (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11:155–168PubMed Allred DC, Harvey JM, Berardo M, Clark GM (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11:155–168PubMed
21.
go back to reference Brasky TM, Bonner MR, Moysich KB et al (2011) Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype. Cancer Causes Control 22:965–975PubMedCrossRef Brasky TM, Bonner MR, Moysich KB et al (2011) Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype. Cancer Causes Control 22:965–975PubMedCrossRef
22.
go back to reference Lee NM, Saha S (2011) Nausea and vomiting of pregnancy. Gastroenterol Clin North Am 40:309–334 viiPubMedCrossRef Lee NM, Saha S (2011) Nausea and vomiting of pregnancy. Gastroenterol Clin North Am 40:309–334 viiPubMedCrossRef
23.
go back to reference Quinla JD, Hill DA (2003) Nausea and vomiting of pregnancy. Am Fam Physician 68:121–128PubMed Quinla JD, Hill DA (2003) Nausea and vomiting of pregnancy. Am Fam Physician 68:121–128PubMed
24.
go back to reference Erlandsson G, Lambe M, Cnattingius S, Ekbom A (2002) Hyperemesis gravidarum and subsequent breast cancer risk. Br J Cancer 87:974–976PubMedCrossRef Erlandsson G, Lambe M, Cnattingius S, Ekbom A (2002) Hyperemesis gravidarum and subsequent breast cancer risk. Br J Cancer 87:974–976PubMedCrossRef
25.
go back to reference Furneaux EC, Langley-Evans AJ, Langley-Evans SC (2001) Nausea and vomiting of pregnancy: endocrine basis and contribution to pregnancy outcome. Obstet Gynecol Surv 56:775–782PubMedCrossRef Furneaux EC, Langley-Evans AJ, Langley-Evans SC (2001) Nausea and vomiting of pregnancy: endocrine basis and contribution to pregnancy outcome. Obstet Gynecol Surv 56:775–782PubMedCrossRef
26.
go back to reference Lawson CC, LeMasters GK, Levin LS, Liu JH (2002) Pregnancy hormone metabolite patterns, pregnancy symptoms, and coffee consumption. Am J Epidemiol 156:428–437PubMedCrossRef Lawson CC, LeMasters GK, Levin LS, Liu JH (2002) Pregnancy hormone metabolite patterns, pregnancy symptoms, and coffee consumption. Am J Epidemiol 156:428–437PubMedCrossRef
27.
go back to reference Masson GM, Anthony F, Chau E (1985) Serum chorionic gonadotrophin (hCG), schwangerschaftsprotein 1 (SP1), progesterone and oestradiol levels in patients with nausea and vomiting in early pregnancy. Br J Obstet Gynaecol 92:211–215PubMedCrossRef Masson GM, Anthony F, Chau E (1985) Serum chorionic gonadotrophin (hCG), schwangerschaftsprotein 1 (SP1), progesterone and oestradiol levels in patients with nausea and vomiting in early pregnancy. Br J Obstet Gynaecol 92:211–215PubMedCrossRef
28.
go back to reference Jarnfelt-Samsioe A (1987) Nausea and vomiting in pregnancy: a review. Obstet Gynecol Surv 42:422–427PubMedCrossRef Jarnfelt-Samsioe A (1987) Nausea and vomiting in pregnancy: a review. Obstet Gynecol Surv 42:422–427PubMedCrossRef
29.
go back to reference Verberg MF, Gillott DJ, Al-Fardan N, Grudzinskas JG (2005) Hyperemesis gravidarum, a literature review. Hum Reprod Update 11:527–539PubMedCrossRef Verberg MF, Gillott DJ, Al-Fardan N, Grudzinskas JG (2005) Hyperemesis gravidarum, a literature review. Hum Reprod Update 11:527–539PubMedCrossRef
30.
go back to reference Broussard CN, Richter JE (1998) Nausea and vomiting of pregnancy. Gastroenterol Clin North Am 27:123–151PubMedCrossRef Broussard CN, Richter JE (1998) Nausea and vomiting of pregnancy. Gastroenterol Clin North Am 27:123–151PubMedCrossRef
31.
go back to reference Guo S, Russo IH, Lareef MH, Russo J (2004) Effect of human chorionic gonadotropin in the gene expression profile of MCF-7 cells. Int J Oncol 24:399–407PubMed Guo S, Russo IH, Lareef MH, Russo J (2004) Effect of human chorionic gonadotropin in the gene expression profile of MCF-7 cells. Int J Oncol 24:399–407PubMed
32.
go back to reference Rao ChV, Li X, Manna SK, Lei ZM, Aggarwal BB (2004) Human chorionic gonadotropin decreases proliferation and invasion of breast cancer MCF-7 cells by inhibiting NF-kappaB and AP-1 activation. J Biol Chem 279:25503–25510PubMedCrossRef Rao ChV, Li X, Manna SK, Lei ZM, Aggarwal BB (2004) Human chorionic gonadotropin decreases proliferation and invasion of breast cancer MCF-7 cells by inhibiting NF-kappaB and AP-1 activation. J Biol Chem 279:25503–25510PubMedCrossRef
33.
go back to reference Russo IH, Russo J (2011) Pregnancy-induced changes in breast cancer risk. J Mammary Gland Biol Neoplasia 16:221–233PubMedCrossRef Russo IH, Russo J (2011) Pregnancy-induced changes in breast cancer risk. J Mammary Gland Biol Neoplasia 16:221–233PubMedCrossRef
34.
go back to reference Bernstein L, Hanisch R, Sullivan-Halley J, Ross RK (1995) Treatment with human chorionic gonadotropin and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 4:437–440PubMed Bernstein L, Hanisch R, Sullivan-Halley J, Ross RK (1995) Treatment with human chorionic gonadotropin and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 4:437–440PubMed
35.
go back to reference Toniolo P, Grankvist K, Wulff M et al (2010) Human chorionic gonadotropin in pregnancy and maternal risk of breast cancer. Cancer Res 70:6779–6786PubMedCrossRef Toniolo P, Grankvist K, Wulff M et al (2010) Human chorionic gonadotropin in pregnancy and maternal risk of breast cancer. Cancer Res 70:6779–6786PubMedCrossRef
36.
go back to reference Ma H, Henderson KD, Sullivan-Halley J et al (2010) Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort. Breast Cancer Res 12:R35PubMedCrossRef Ma H, Henderson KD, Sullivan-Halley J et al (2010) Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort. Breast Cancer Res 12:R35PubMedCrossRef
37.
go back to reference Enger SM, Ross RK, Henderson B, Bernstein L (1997) Breastfeeding history, pregnancy experience and risk of breast cancer. Br J Cancer 76:118–123PubMedCrossRef Enger SM, Ross RK, Henderson B, Bernstein L (1997) Breastfeeding history, pregnancy experience and risk of breast cancer. Br J Cancer 76:118–123PubMedCrossRef
38.
go back to reference Troisi R, Potischman N, Roberts JM et al (2003) Maternal serum oestrogen and androgen concentrations in preeclamptic and uncomplicated pregnancies. Int J Epidemiol 32:455–460PubMedCrossRef Troisi R, Potischman N, Roberts JM et al (2003) Maternal serum oestrogen and androgen concentrations in preeclamptic and uncomplicated pregnancies. Int J Epidemiol 32:455–460PubMedCrossRef
39.
go back to reference Hubinette A, Lichtenstein P, Brismar K et al (2003) Serum insulin-like growth factors in normal pregnancy and in pregnancies complicated by preeclampsia. Acta Obstet Gynecol Scand 82:1004–1009PubMed Hubinette A, Lichtenstein P, Brismar K et al (2003) Serum insulin-like growth factors in normal pregnancy and in pregnancies complicated by preeclampsia. Acta Obstet Gynecol Scand 82:1004–1009PubMed
40.
go back to reference Calderon-Margalit R, Friedlander Y, Yanetz R et al (2009) Preeclampsia and subsequent risk of cancer: update from the Jerusalem Perinatal Study. Am J Obstet Gynecol 200(63):e1–e5PubMed Calderon-Margalit R, Friedlander Y, Yanetz R et al (2009) Preeclampsia and subsequent risk of cancer: update from the Jerusalem Perinatal Study. Am J Obstet Gynecol 200(63):e1–e5PubMed
41.
go back to reference Opdahl S, Romundstad PR, Alsaker MD, Vatten LJ (2012) Hypertensive diseases in pregnancy and breast cancer risk. Br J Cancer 107:176–182PubMedCrossRef Opdahl S, Romundstad PR, Alsaker MD, Vatten LJ (2012) Hypertensive diseases in pregnancy and breast cancer risk. Br J Cancer 107:176–182PubMedCrossRef
42.
go back to reference Paltiel O, Friedlander Y, Tiram E, Barchana M, Xue X, Harlap S (2004) Cancer after pre-eclampsia: follow up of the Jerusalem perinatal study cohort. BMJ 328:919PubMedCrossRef Paltiel O, Friedlander Y, Tiram E, Barchana M, Xue X, Harlap S (2004) Cancer after pre-eclampsia: follow up of the Jerusalem perinatal study cohort. BMJ 328:919PubMedCrossRef
43.
go back to reference Vatten LJ, Forman MR, Nilsen TI, Barrett JC, Romundstad PR (2007) The negative association between pre-eclampsia and breast cancer risk may depend on the offspring’s gender. Br J Cancer 96:1436–1438PubMed Vatten LJ, Forman MR, Nilsen TI, Barrett JC, Romundstad PR (2007) The negative association between pre-eclampsia and breast cancer risk may depend on the offspring’s gender. Br J Cancer 96:1436–1438PubMed
44.
go back to reference Vatten LJ, Romundstad PR, Trichopoulos D, Skjaerven R (2002) Pre-eclampsia in pregnancy and subsequent risk for breast cancer. Br J Cancer 87:971–973PubMedCrossRef Vatten LJ, Romundstad PR, Trichopoulos D, Skjaerven R (2002) Pre-eclampsia in pregnancy and subsequent risk for breast cancer. Br J Cancer 87:971–973PubMedCrossRef
45.
go back to reference Cohn BA, Cirillo PM, Christianson RE, van den Berg BJ, Siiteri PK (2001) Placental characteristics and reduced risk of maternal breast cancer. J Natl Cancer Inst 93:1133–1140PubMedCrossRef Cohn BA, Cirillo PM, Christianson RE, van den Berg BJ, Siiteri PK (2001) Placental characteristics and reduced risk of maternal breast cancer. J Natl Cancer Inst 93:1133–1140PubMedCrossRef
46.
go back to reference Innes KE, Byers TE (2004) First pregnancy characteristics and subsequent breast cancer risk among young women. Int J Cancer 112:306–311PubMedCrossRef Innes KE, Byers TE (2004) First pregnancy characteristics and subsequent breast cancer risk among young women. Int J Cancer 112:306–311PubMedCrossRef
47.
go back to reference Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B (2005) Diabetes mellitus and breast cancer. Lancet Oncol 6:103–111PubMedCrossRef Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B (2005) Diabetes mellitus and breast cancer. Lancet Oncol 6:103–111PubMedCrossRef
48.
go back to reference Rollison DE, Giuliano AR, Sellers TA et al (2008) Population-based case–control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states. Am J Epidemiol 167:447–456PubMedCrossRef Rollison DE, Giuliano AR, Sellers TA et al (2008) Population-based case–control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states. Am J Epidemiol 167:447–456PubMedCrossRef
49.
go back to reference Dawson SI (2004) Long-term risk of malignant neoplasm associated with gestational glucose intolerance. Cancer 100:149–155PubMedCrossRef Dawson SI (2004) Long-term risk of malignant neoplasm associated with gestational glucose intolerance. Cancer 100:149–155PubMedCrossRef
50.
go back to reference Perrin MC, Terry MB, Kleinhaus K et al (2008) Gestational diabetes and the risk of breast cancer among women in the Jerusalem Perinatal Study. Breast Cancer Res Treat 108:129–135PubMedCrossRef Perrin MC, Terry MB, Kleinhaus K et al (2008) Gestational diabetes and the risk of breast cancer among women in the Jerusalem Perinatal Study. Breast Cancer Res Treat 108:129–135PubMedCrossRef
51.
go back to reference Sella T, Chodick G, Barchana M et al (2011) Gestational diabetes and risk of incident primary cancer: a large historical cohort study in Israel. Cancer Causes Control 22:1513–1520PubMedCrossRef Sella T, Chodick G, Barchana M et al (2011) Gestational diabetes and risk of incident primary cancer: a large historical cohort study in Israel. Cancer Causes Control 22:1513–1520PubMedCrossRef
52.
go back to reference Hilakivi-Clarke L, Luoto R, Huttunen T, Koskenvuo M (2005) Pregnancy weight gain and premenopausal breast cancer risk. J Reprod Med 50:811–816PubMed Hilakivi-Clarke L, Luoto R, Huttunen T, Koskenvuo M (2005) Pregnancy weight gain and premenopausal breast cancer risk. J Reprod Med 50:811–816PubMed
53.
go back to reference Kinnunen TI, Luoto R, Gissler M, Hemminki E, Hilakivi-Clarke L (2004) Pregnancy weight gain and breast cancer risk. BMC Womens Health 4:7PubMedCrossRef Kinnunen TI, Luoto R, Gissler M, Hemminki E, Hilakivi-Clarke L (2004) Pregnancy weight gain and breast cancer risk. BMC Womens Health 4:7PubMedCrossRef
54.
go back to reference Peterson NB, Huang Y, Newcomb PA et al (2008) Childbearing recency and modifiers of premenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 17:3284–3287PubMedCrossRef Peterson NB, Huang Y, Newcomb PA et al (2008) Childbearing recency and modifiers of premenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 17:3284–3287PubMedCrossRef
55.
go back to reference Olson JE, Shu XO, Ross JA, Pendergrass T, Robison LL (1997) Medical record validation of maternally reported birth characteristics and pregnancy-related events: a report from the Children’s Cancer Group. Am J Epidemiol 145:58–67PubMedCrossRef Olson JE, Shu XO, Ross JA, Pendergrass T, Robison LL (1997) Medical record validation of maternally reported birth characteristics and pregnancy-related events: a report from the Children’s Cancer Group. Am J Epidemiol 145:58–67PubMedCrossRef
56.
go back to reference Souza JP, Cecatti JG, Pacagnella RC et al (2010) Development and validation of a questionnaire to identify severe maternal morbidity in epidemiological surveys. Reproductive health 7:16PubMedCrossRef Souza JP, Cecatti JG, Pacagnella RC et al (2010) Development and validation of a questionnaire to identify severe maternal morbidity in epidemiological surveys. Reproductive health 7:16PubMedCrossRef
57.
go back to reference Nielsen TO, Hsu FD, Jensen K et al (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10:5367–5374PubMedCrossRef Nielsen TO, Hsu FD, Jensen K et al (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10:5367–5374PubMedCrossRef
Metadata
Title
Pregnancy-related characteristics and breast cancer risk
Authors
Theodore M. Brasky
Yanli Li
David J. Jaworowicz Jr.
Nancy Potischman
Christine B. Ambrosone
Alan D. Hutson
Jing Nie
Peter G. Shields
Maurizio Trevisan
Carole B. Rudra
Stephen B. Edge
Jo L. Freudenheim
Publication date
01-09-2013
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 9/2013
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-013-0242-9

Other articles of this Issue 9/2013

Cancer Causes & Control 9/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine